| IN(n = 56) | SEN(n = 56) | P |
---|---|---|---|
WBC(*109/L)  Baseline  PrOD  POD1  POD3  POD5 | 6.06 ± 1.30 5.46 ± 1.27 9.19 ± 2.64 6.81 ± 1.62 6.10 ± 1.45 | 6.46 ± 1.54 6.15 ± 1.55 10.40 ± 2.76 8.61 ± 2.88 6.78 ± 2.64 | 0.137 0.011 0.019 <0.001 0.034 |
CRP(mg/L)  Baseline  PrOD  POD1  POD3  POD5 | 2.44(1.06–4.76) 1.19(0.51–3.05) 18.06(9.21–38.99) 65.83(46.40–92.30) 33.46(20.26–57.67) | 2.25(0.94–5.35) 2.66(1.07–7.18) 35.99(15.10-66.23) 80.03(55.52-122.34) 39.18(25.78–70.41) | 0.798 0.005 0.003 0.042 0.295 |
PCT(ng/mL)  Baseline  PrOD  POD1  POD3  POD5 | 0.05(0.03–0.06) 0.04(0.03–0.06) 0.09(0.07–0.15) 0.12(0.08–0.18) 0.10(0.07–0.20) | 0.05(0.02–0.06) 0.05(0.04–0.07) 0.08(0.05–0.12) 0.11(0.07–0.18) 0.09(0.06–0.15) | 0.328 0.151 0.099 0.532 0.474 |
IL-1(pg/mL)  Baseline  PrOD  POD3 | 1.70(1.55–5.78) 1.55(1.55–2.52) 1.55(1.55–1.79) | 1.55(1.55–4.40) 1.55(1.55–1.79) 1.55(1.55–1.79) | 0.530 0.506 0.839 |
IL-6(pg/mL)  Baseline  PrOD  POD3 | 1.74(1.74–3.66) 1.74(1.74–3.15) 18.06(1.74–63.86) | 1.74(1.74–3.99) 1.74(1.74–3.99) 45.97(9.43–69.97) | 0.519 0.448 0.048 |
IL-8(pg/mL)  Baseline  PrOD  POD3 | 1.89(1.89–43.46) 1.89(1.89–38.20) 1.89(1.89–5.32) | 1.89(1.89–43.46) 1.89(1.89–43.46) 1.89(1.89–17.17) | 0.621 0.921 0.925 |
IFN-γ(pg/mL)  Baseline  PrOD  POD3 | 1.78(1.78-3.00) 1.78(1.78–3.02) 1.78(1.78–2.13) | 2.08(1.78–3.20) 2.24(1.78–3.45) 1.78(1.78–1.78) | 0.651 0.401 0.465 |
TNF-α(pg/mL)  Baseline  PrOD  POD3 | 2.03(2.03–2.03) 2.03(2.03–2.03) 2.03(2.03–2.03) | 2.03(2.03–2.03) 2.03(2.03–2.03) 2.03(2.03–2.03) | 0.504 0.750 0.949 |